Recent advances in diagnostic technologies for autoimmune diseases

Autoimmunity Reviews

Volumn 8, Issue 3, 2009, Pages 238-243

  Plebani, Mario ^a   Pittoni, Marina ^a   Celadin, Marilena ^a   Bernardi, Daniela ^a   Mion, Monica Maria ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

"omics" research; Antigen microarrays; Autoantibody profiling; Autoimmune diseases; Mass spectrometry

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER;

AUTOIMMUNE DISEASE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; DNA MICROARRAY; DNA PROBE; HUMAN; IMMUNE RESPONSE; MASS SPECTROMETRY; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TRADITIONAL MEDICINE;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC TESTS; MASS SPECTROMETRY; ORGAN SPECIFICITY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 58149475870     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.032     Document Type: Review

References (30)

1. Plebani M. Proteomics: the next revolution in laboratory medicine?. Clin Chim Acta 357 (2005) 113-122
2. Davidson A., and Diamond B. Autoimmune disease. N Engl J Med 345 (2001) 340-350
3. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34 (2004) 501-537
4. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 6 (2007) 334-340
5. Villalta D., Tozzoli R., Tonutti E., and Bizzaro N. The laboratory approach to the diagnosis of autoimmune diseases: it is time to change?. Autoimmun Rev 6 (2007) 359-365
6. Dotzlaw H., Eggert M., Neeck G., and Schulz M. Spots, blots, peaks and chips: proteomic approaches in autoimmune diseases. Curr Pharmacol Design 12 (2006) 3699-3706
7. Gonzàles-Buitrago J.M. Multiplexed testing in the autoimmunity laboratory. Clin Chem Lab Med 44 (2006) 1169-1174
8. Astle J.M., and Kodadek T. Microarray approaches to autoantibody profiling. In: Van Eyk J., and Dunn M.J. (Eds). Clinical Proteomics. From diagnosis to therapy (2008), Weinheim, WILEY-VCH Verlag 511-132
9. Ekins R.P. Multi-analyte immunoassay. J Pharm Biomed Anal 7 (1989) 155-168
10. Fodor S.P., Read J.L., Pirrung M.C., Stryer L., Lu A.T., and Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 251 (1991) 767-773
11. Joos T.O., Schrenk M., Hopfl P., Kroger K., Chowdhury U., Stoll D., et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21 (2000) 2641-2650
12. Robinson W.H., Di Gennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8 (2002) 295-301
13. Hueber W., Utz P.J., Steinman L., and Robinson W.H. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res 5 (2002) 290-295
14. Haab B.B., Dunham M.J., and Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2 (2001) research0004.0001-0004.0013
15. Fulton R.J., McDade R.L., Smith P.L., and Kienker L.J. Advanced multiplexed analysis with the FluoMetrix system. Clin Chem 43 (1997) 1749-1756
16. Nicewarner-Pena S.R., Freeman R.G., Reiss B.D., He L., Pena D.J., Walton I.D., Cromer R., Keating C.D., and Natan M.J. Submicrometer metallic barcodes. . Science 294 (2001) 137-141
17. Santiago J.G., Wereley S.T., Meinhart C.D., Beebee D.J., and Adrian R.J. A particle image velocimetry system for microfluidics. Exp Fluids 25 (1998) 316-319
18. Bizzaro N., Bonelli F., Tonutti E., Tozzoli R., and Villalta D. New couplet-particle light-scattering assay for the detection of Ro/SSA and La/SSB autoantibodies in connetice tissue diseases. Clin Diagn Lab Immunol 8 (2001) 922-925
19. Robinson W.H., Steinman L., and Utz P.J. Proteomics technology for the study of autoimmune disease. Arthritis Rheum 46 (2002) 885-893
20. Grus F.H., Joachim S.C., and Pfeiffer N. Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics 3 (2003) 957-961
21. Liotta L.A., and Petricoin E.F. Putting the "Bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. Clin Chem 54 (2008) 3-5
22. Hortin G.L., Jortani S.A., Ritchie J.C., Valdes R., and Chan D.W. Proteomics: a new diagnostic frontier. Clin Chem 52 (2006) 1218-1222
23. Lippi G., Guidi G.C., Mattiuzzi C., and Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 44 (2006) 358-365
24. Banks R.E. Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking. Clin Chem 54 (2008) 6-7
25. Hortin G.L. Can mass spectrometry protein profiling meet desired standards of clinical laboratory practice?. Clin Chem 51 (2005) 3-5
26. Plebani M., and Laposata M. Translational research involving new biomarkers of disease. A leading role for pathologists. AJCP 126 (2006) 169-171
27. Plebani M., and Marincola F.M. Research translation: a new frontier for clinical laboratories. Clin Chem Lab Med 44 (2006) 1303-1312
28. Ransohoff D.F. Evaluating discovery-based research: when biologic reasoning cannot work. Gastroenterology 127 (2004) 1028
29. Ransohoff D.F. Bias as a threat to the validity of cancer-molecular-marker research. Nature Rev Cancer 5 (2005) 142-149
30. Ransohoff D.F. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. J Clin Epidemiol 60 (2007) 1205-1219